Dermatology is one of the most complex areas of medical aid coverage in South Africa. Most common skin conditions — acne, rosacea, fungal infections, urticaria — are day-to-day; some require expensive treatments that are not CDL or PMB; and others (severe burns, skin cancer, psoriasis, eczema) are PMB-covered or CDL. The cosmetic vs medical distinction creates significant coverage battles. This guide covers the most common SA skin conditions and how your medical aid treats them.
The Core Principle: Medical vs Cosmetic
Medical treatment of skin conditions = covered under your benefit structure (day-to-day, PMB, CDL as applicable). Cosmetic treatment = not covered.
The challenge: many conditions sit at the boundary. Keloid removal, vitiligo, rosacea, acne — these have functional and psychological consequences but are often classified as cosmetic by schemes. The dispute resolution pathway (CMS) exists for cases where schemes inappropriately classify genuinely medical conditions as cosmetic.
Conditions That Are PMB or CDL
Severe Burns (PMB)
Burns covering ≥15% of total body surface area (TBSA) in adults (lower threshold in children) are PMB-covered. All burn treatment — resuscitation, ICU admission, skin grafting, wound management — must be funded.
Burns <15% TBSA are treated as acute PMB events if the circumstances constitute an emergency (admission, IV resuscitation, urgent surgery). Minor burns can be managed at day-to-day level.
Psoriasis (CDL)
Psoriasis is on the CDL. Your scheme must fund topical treatments and systemic treatments (methotrexate, biologics for moderate-severe disease) under the CDL chronic medication benefit. See the dedicated Psoriasis article for the full coverage guide.
Eczema / Atopic Dermatitis (CDL — via Allergic Rhinitis CDL or via scheme programme)
Eczema (atopic dermatitis) is associated with atopy (allergy). Moderate-severe eczema requiring dupilumab (Dupixent) qualifies for exceptional-needs coverage via clinical motivation. See the dedicated Eczema article for coverage details.
Skin Cancer (PMB — Cancer DTP)
All skin cancers — basal cell carcinoma (BCC), squamous cell carcinoma (SCC), melanoma — are PMB-covered as cancer DTPs. Surgery (wide local excision, Mohs surgery), radiotherapy, immunotherapy (pembrolizumab, nivolumab for advanced melanoma), and BRAF/MEK inhibitors (dabrafenib/trametinib for BRAF-mutated melanoma) are all PMB-funded under the oncology DTP.
Skin cancer screening (annual dermatology check for melanoma risk, mole surveillance) is NOT PMB — it is preventive and day-to-day/OOP. Cost: R1,500–R3,000 at a dermatologist.
Common Conditions That Are Day-to-Day
Acne
Acne is extremely common in South Africa. Dermatology management is straightforward and generally well-funded from day-to-day benefit.
Day-to-day treatments (formulary): - Benzoyl peroxide + topical antibiotic (clindamycin) — generic; R150–R400/month - Topical retinoid (adapalene/tretinoin) — R200–R500/month - Oral doxycycline or minocycline — R200–R500/month - Combined oral contraceptive (COC) for hormonal acne in women — funded via contraception benefit in most schemes
Isotretinoin (Roaccutane / Oratane / Acnetane): - Oral isotretinoin is the most effective acne treatment — achieves >80% clearance in severe nodularcystic acne - Cost: R300–R600/month (generic; brand is more expensive) - Funded from day-to-day benefit — confirm formulary - Requires monthly monitoring (pregnancy test for women, LFTs, lipids) — day-to-day pathology - iPLEDGE/pregnancy prevention programme: all women on isotretinoin must use 2 forms of contraception and have monthly negative pregnancy tests — strictly enforced
Rosacea
Rosacea is a chronic facial redness condition affecting fair-skinned adults, common in SA's professional population. Not CDL, not PMB. Day-to-day management.
Day-to-day treatments: - Metronidazole 0.75% topical gel (Rosiced) — R350–R600/month - Azelaic acid 15% (Finacea) — R450–R700/month - Oral doxycycline 40mg modified-release (Oracea) — R800–R1,500/month (more expensive); anti-inflammatory dose - Brimonidine topical (Mirvaso — for flushing/redness) — R700–R1,200/month; not widely available
Laser treatment (PDL, IPL) for rosacea: cosmetic classification — NOT covered.
Vitiligo
Vitiligo — depigmented white patches caused by autoimmune destruction of melanocytes — is not CDL, not PMB. Treatments are day-to-day.
Day-to-day treatments: - Topical calcineurin inhibitors (tacrolimus/pimecrolimus) — off-label but used for facial vitiligo; R400–R800/month - Narrowband UVB phototherapy (NBUVB): 3×/week sessions; can be funded from day-to-day specialist benefit; R600–R1,200/session; 30–60 sessions needed - Ruxolitinib cream (Opzelura — JAK inhibitor): recently approved for vitiligo; not available in SA as of 2025; exceptional-needs consideration if available
Cosmetic camouflage is OOP and not covered.
Urticaria (Hives) and Chronic Spontaneous Urticaria (CSU)
Acute urticaria responds to antihistamines — day-to-day, inexpensive.
Chronic spontaneous urticaria (CSU) — urticaria persisting >6 weeks without identifiable trigger — can be severe and disabling.
Day-to-day: Non-sedating antihistamines (cetirizine, loratadine) at licensed and up-dosed levels; montelukast (leukotriene receptor antagonist).
Omalizumab (Xolair) for refractory CSU: - Cost: R10,000–R15,000/month SC injection - Not CDL. Requires exceptional-needs authorisation from your scheme's medical director - Indication: CSU refractory to high-dose antihistamines + montelukast, documented over 3 months - Submit through allergy or dermatology specialist with clinical motivation
Fungal Skin Infections
Very common in SA's warm climate and overcrowded settings.
Tinea pedis (athlete's foot), tinea corporis (ringworm), tinea cruris (jock itch): - Topical clotrimazole or miconazole cream — OTC, R80–R200/course - Oral terbinafine for nail fungal infections (onychomycosis) — generic: R200–R400/month for 3–6 months
Pityriasis versicolor: Ketoconazole shampoo (used as body wash) — inexpensive; widely available.
All are day-to-day costs, funded from MSA/ATB.
Keloids
Keloids (hypertrophic scar tissue overgrowth) are extremely common in SA, particularly in people of African descent, due to genetic predisposition.
Coverage: Keloid treatment is frequently classified as cosmetic by schemes. However, keloids that cause pain, restrict movement, or occur over joints have a functional/medical component — and can be argued as medical treatment.
Day-to-day treatments: - Intralesional corticosteroid injections — R500–R800/session; multiple sessions required - Silicone sheets — OOP; R200–R600 - Cryotherapy — R500–R1,000/session
Surgical excision + adjuvant radiation or corticosteroid: For large keloids; expensive. Surgical excision alone frequently causes recurrence. Pre-authorise; argue medical necessity if there is pain or functional impairment.
Cosmetic vs Medical — Where the Lines Are Drawn
| Treatment | Typically covered | Notes |
|---|---|---|
| Acne scar treatment (CO2 laser, chemical peels) | No — cosmetic | OOP |
| Wrinkle treatment (Botox, fillers) | No — cosmetic | OOP always |
| Hyperpigmentation treatment (melasma, PIH) | No — cosmetic | OOP |
| Hair loss (androgenetic alopecia) | No — cosmetic | OOP; finasteride generic R150–R300/month OOP |
| Excessive sweating (hyperhidrosis — axillary Botox) | No — usually cosmetic | Occasional exception for severe axillary hyperhidrosis |
| Tattoo removal | No — cosmetic | OOP always |
| Keloid with pain/functional impairment | Partially — argue medical | Document functional impact |
| Skin cancer surgery | Yes — PMB | Not cosmetic; cancer DTP |
| Burns ≥15% TBSA | Yes — PMB | Emergency |
| Severe psoriasis biologic therapy | Yes — CDL | Clinical motivation required |
| Severe eczema — dupilumab | Yes — exceptional-needs | Specialist motivation required |
Dermatologist Consultation — Day-to-Day Cost
Dermatologist consultation is day-to-day (funded from MSA/ATB, not PMB).
Cost: R1,000–R2,500/consultation depending on scheme tariff and dermatologist's rate. Most private dermatologists charge above scheme rate. Gap cover does not typically apply to outpatient consultations — this is a pure day-to-day cost.
State dermatology clinics: Significant waiting times (3–12 months) but excellent care for complex conditions. Available as a cost-effective option.
Dermatology Helplines and Resources
SADSA (South African Dermatology Society): Dermatologist finder — dermsa.co.za CANSA helpline (skin cancer): 0800 22 6622 Council for Medical Schemes (cosmetic vs medical disputes): 0861 123 267
Cross-References
Talk to Eldon
Dermatology coverage is highly variable across plans — from formulary access for isotretinoin to exceptional-needs coverage for biologics. The Check shows what each plan on our panel pays for this, side by side, and Eldon advises from there.
See which plans pay for dermatology and skin conditions →